Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IOMA Paris is a pioneer in the "Beauty Tech" sector, specializing in personalized skincare through advanced skin analysis technology. Founded by Jean Michel Karam, the company utilizes MEMS (Micro-Electro-Mechanical Systems) and high-tech diagnostic devices like the IOMA Sphere to provide deep-tissue skin assessments. These diagnostics allow for the creation of bespoke skincare formulations tailored to an individual's specific dermatological needs. By bridging the gap between high-tech engineering and cosmetic science, IOMA offers evidence-based beauty solutions with measurable results. The company operates globally, partnering with major retailers and luxury spas to deliver its data-driven skincare experience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IOMA.